Lista de obras -

68Ga-TRAP-(RGD)3 Hybrid Imaging for the In Vivo Monitoring of αvß3-Integrin Expression as Biomarker of Anti-Angiogenic Therapy Effects in Experimental Breast Cancer

artículo científico publicado en 2016

A novel real-space navigation paradigm reveals age- and gender-dependent changes of navigational strategies and hippocampal activation

scientific article published on 02 August 2018

Additive value of amyloid-PET in routine cases of clinical dementia work-up after FDG-PET.

artículo científico publicado en 2017

Altered serotonin and dopamine transporter availabilities in brain of depressed patients upon treatment with escitalopram: A [123 I]β-CIT SPECT study.

artículo científico publicado en 2015

Amyloid-PET predicts inhibition of de novo plaque formation upon chronic γ-secretase modulator treatment

artículo científico publicado en 2015

Analysis of 18F-DMFP PET data using multikernel classification in order to assist the diagnosis of Parkinsonism

scholarly article published October 2015

Applied multimodal diagnostics in a case of presenile dementia.

artículo científico publicado en 2016

Assessment of 18F-PI-2620 as a Biomarker in Progressive Supranuclear Palsy

artículo científico publicado en 2020

Associations of [18F]-APN-1607 Tau PET Binding in the Brain of Alzheimer's Disease Patients With Cognition and Glucose Metabolism

artículo científico publicado en 2020

Asymmetry of fibrillar plaque burden in amyloid mouse models

scientific article published on 15 May 2020

Automated Spatial Brain Normalization and Hindbrain White Matter Reference Tissue Give Improved [(18)F]-Florbetaben PET Quantitation in Alzheimer's Model Mice

artículo científico publicado en 2016

Cerebral Glucose Metabolism and Dopaminergic Function in Patients with Corticobasal Syndrome

artículo científico publicado en 2016

Clinical Routine FDG-PET Imaging of Suspected Progressive Supranuclear Palsy and Corticobasal Degeneration: A Gatekeeper for Subsequent Tau-PET Imaging?

artículo científico publicado en 2018

Clinical, ocular motor, and imaging profile of Niemann-Pick type C heterozygosity

artículo científico publicado en 2020

Colocalization of Tau but Not β-Amyloid with Cortical Superficial Siderosis in a Case with Probable CAA

artículo científico publicado en 2020

Comparison of 18F-GE-180 and dynamic 18F-FET PET in high grade glioma: a double-tracer pilot study

scientific article published on 22 September 2018

Comparison of 18F-T807 and 18F-THK5117 PET in a Mouse Model of Tau Pathology.

artículo científico publicado en 2018

Coupling between physiological TSPO expression in brain and myocardium allows stabilization of late-phase cerebral [18F]GE180 PET quantification

artículo científico publicado en 2017

Cross-sectional comparison of small animal [18F]-florbetaben amyloid-PET between transgenic AD mouse models

artículo científico publicado en 2015

Data on specificity of [18F]GE180 uptake for TSPO expression in rodent brain and myocardium.

artículo científico publicado en 2018

Depressive symptoms accelerate cognitive decline in amyloid-positive MCI patients

artículo científico publicado en 2015

Detection of Cerebrospinal Fluid Dissemination of Recurrent Glioblastoma Using TSPO-PET With 18F-GE-180.

artículo científico publicado en 2018

Direct comparison of activation maps during galvanic vestibular stimulation: A hybrid H2[15 O] PET-BOLD MRI activation study

artículo científico publicado en 2020

Early and Longitudinal Microglial Activation but Not Amyloid Accumulation Predicts Cognitive Outcome in PS2APP Mice

scientific article published on 27 September 2018

Early static (18)F-FET-PET scans have a higher accuracy for glioma grading than the standard 20-40 min scans.

artículo científico publicado en 2015

Early-phase [18F]PI-2620 tau-PET imaging as a surrogate marker of neuronal injury

scientific article published on 21 April 2020

Efficacy of chronic BACE1 inhibition in PS2APP mice depends on the regional Aβ deposition rate and plaque burden at treatment initiation

scientific article published on 09 September 2018

Evaluation of early-phase [18F]-florbetaben PET acquisition in clinical routine cases

artículo científico publicado en 2016

Expression of Translocator Protein and [18F]-GE180 Ligand Uptake in Multiple Sclerosis Animal Models

FDG PET Data is Associated with Cognitive Performance in Patients from a Memory Clinic

scientific article published on 11 September 2020

FDG-PET in a Case of Very Late-onset Huntington's Disease

scientific article published on 23 March 2018

Four-repeat tauopathies

artículo científico publicado en 2019

Glial Activation and Glucose Metabolism in a Transgenic Amyloid Mouse Model: A Triple-Tracer PET Study

artículo científico publicado en 2016

Glial activation is moderated by sex in response to amyloidosis but not to tau pathology in mouse models of neurodegenerative diseases

artículo científico publicado en 2020

Higher CSF sTREM2 and microglia activation are associated with slower rates of beta-amyloid accumulation

artículo científico publicado en 2020

Hypometabolism in Brain of Cognitively Normal Patients with Depressive Symptoms is Accompanied by Atrophy-Related Partial Volume Effects

artículo científico publicado en 2016

Identification of Distant Metastases From Recurrent Gliosarcoma Using Whole-Body 18F-FDG PET/CT

artículo científico publicado en 2019

Identification of a rare presenilin 1 single amino acid deletion mutation (F175del) with unusual amyloid-β processing effects

scientific article published on 20 September 2019

Identification of brain regions predicting epileptogenesis by serial [18F]GE-180 positron emission tomography imaging of neuroinflammation in a rat model of temporal lobe epilepsy

artículo científico publicado en 2017

IgLON5: A case with predominant cerebellar tau deposits and leptomeningeal inflammation

artículo científico publicado en 2018

Imaging biomarkers of behavioral impairments: A pilot micro-positron emission tomographic study in a rat electrical post-status epilepticus model

artículo científico publicado en 2018

Imaging correlates of behavioral impairments: An experimental PET study in the rat pilocarpine epilepsy model

artículo científico publicado en 2018

Impact of MRI-based Segmentation Artifacts on Amyloid- and FDG-PET Quantitation

artículo científico publicado en 2016

Impact of partial volume effect correction on cerebral β-amyloid imaging in APP-Swe mice using [(18)F]-florbetaben PET.

artículo científico publicado en 2013

Improved Risk Stratification for Progression from Mild Cognitive Impairment to Alzheimer's Disease with a Multi-Analytical Evaluation of Amyloid-β Positron Emission Tomography

scientific article published on 01 January 2020

Improved longitudinal [(18)F]-AV45 amyloid PET by white matter reference and VOI-based partial volume effect correction

artículo científico publicado en 2014

In Vivo Imaging of Glial Activation after Unilateral Labyrinthectomy in the Rat: A [18F]GE180-PET Study

artículo científico publicado en 2017

In response to: Anatomy of 18F-GE180, a failed radioligand for the TSPO protein

artículo científico publicado en 2020

In response to: The validity of 18F-GE180 as a TSPO imaging agent

artículo científico publicado en 2019

Increase of TREM2 during Aging of an Alzheimer's Disease Mouse Model Is Paralleled by Microglial Activation and Amyloidosis

artículo científico publicado en 2017

Laquinimod ameliorates secondary brain inflammation

artículo científico publicado en 2019

Late-stage Anle138b treatment ameliorates tau pathology and metabolic decline in a mouse model of human Alzheimer's disease tau

artículo científico publicado en 2019

Longitudinal PET Monitoring of Amyloidosis and Microglial Activation in a Second-Generation Amyloid-β Mouse Model

artículo científico publicado en 2019

Longitudinal TSPO expression in tau transgenic P301S mice predicts increased tau accumulation and deteriorated spatial learning

artículo científico publicado en 2020

Longitudinal assessment of cerebral β-amyloid deposition in mice overexpressing Swedish mutant β-amyloid precursor protein using 18F-florbetaben PET.

artículo científico publicado en 2013

Loss of TMEM106B potentiates lysosomal and FTLD-like pathology in progranulin-deficient mice

scientific article published on 14 September 2020

Loss of TREM2 function increases amyloid seeding but reduces plaque-associated ApoE

scientific article published on 07 January 2019

Mapping 3-year changes in gray matter and metabolism in Aβ-positive nondemented subjects

artículo científico publicado en 2015

Metabolic Correlates of Dopaminergic Loss in Dementia with Lewy Bodies

artículo científico publicado en 2019

Metabolic patterns across core features in dementia with lewy bodies

scientific article published on 22 March 2019

Microglial response to increasing amyloid load saturates with aging: a longitudinal dual tracer in vivo μPET-study

Molecular imaging of cardiac CXCR4 expression in a mouse model of acute myocardial infarction using a novel 68Ga-mCXCL12 PET tracer

artículo científico publicado en 2020

Monitoring of Tumor Growth with [(18)F]-FET PET in a Mouse Model of Glioblastoma: SUV Measurements and Volumetric Approaches

scientific article published on 14 June 2016

Monitoring of chronic γ-secretase modulator treatment by serial amyloid-PET.

artículo científico publicado en 2015

Multivariate Analysis of 18F-DMFP PET Data to Assist the Diagnosis of Parkinsonism

artículo científico publicado en 2017

Neuronal injury biomarkers for assessment of the individual cognitive reserve in clinically suspected Alzheimer's disease

artículo científico publicado en 2019

Noradrenaline transporter availability on [11C]MRB PET predicts weight loss success in highly obese adults.

artículo científico publicado en 2018

Opposite microglial activation stages upon loss of PGRN or TREM2 result in reduced cerebral glucose metabolism.

artículo científico publicado en 2019

PET Imaging of Astrogliosis and Tau Facilitates Diagnosis of Parkinsonian Syndromes

scientific article published on 11 September 2019

Perfusion-Phase [18F]THK5351 Tau-PET Imaging as a Surrogate Marker for Neurodegeneration

scientific article published on 28 September 2017

Predicting Regional Pattern of Longitudinal β-Amyloid Accumulation by Baseline PET.

artículo científico publicado en 2016

Prevalence of Amyloid Positron Emission Tomographic Positivity in Poststroke Mild Cognitive Impairment

artículo científico

Rate of β-amyloid accumulation varies with baseline amyloid burden: Implications for anti-amyloid drug trials

scientific article published on 04 July 2018

Real-space navigation testing differentiates between amyloid-positive and -negative aMCI

artículo científico publicado en 2020

Reduced FDG-PET brain metabolism and executive function predict clinical progression in elderly healthy subjects

artículo científico publicado en 2013

Reference region selection and the association between the rate of amyloid accumulation over time and the baseline amyloid burden

artículo científico publicado en 2017

Relationship Between Body Mass Index, ApoE4 Status, and PET-Based Amyloid and Neurodegeneration Markers in Amyloid-Positive Subjects with Normal Cognition or Mild Cognitive Impairment

artículo científico publicado en 2017

Serotonin Selective Reuptake Inhibitor Treatment Improves Cognition and Grey Matter Atrophy but not Amyloid Burden During Two-Year Follow-Up in Mild Cognitive Impairment and Alzheimer's Disease Patients with Depressive Symptoms

artículo científico publicado en 2018

Small-Animal PET Imaging of Tau Pathology with 18F-THK5117 in 2 Transgenic Mouse Models

artículo científico publicado en 2016

Stereological Investigation of Regional Brain Volumes after Acute and Chronic Cuprizone-Induced Demyelination

scientific article published on 03 September 2019

Superior vena cava syndrome related to mediastinal lymphoma in late pregnancy: A case report

scientific article published on 26 May 2018

Suspected recurrence of brain metastases after focused high dose radiotherapy: can [18F]FET- PET overcome diagnostic uncertainties?

artículo científico publicado en 2016

TSPO PET With 18F-GE-180 to Differentiate Variants of Multiple Sclerosis: Relapsing-Remitting Multiple Sclerosis, Tumefactive Demyelination, and Baló's Concentric Sclerosis

scientific article published on 11 August 2020

TSPO PET for glioma imaging using the novel ligand (18)F-GE-180: first results in patients with glioblastoma

artículo científico

TSPO PET with [18F]GE-180 sensitively detects focal neuroinflammation in patients with relapsing-remitting multiple sclerosis.

artículo científico publicado en 2018

TSPO PET, tumour grading and molecular genetics in histologically verified glioma: a correlative 18F-GE-180 PET study

scientific article published on 05 September 2019

TSPO imaging using the novel PET ligand [18F]GE-180: quantification approaches in patients with multiple sclerosis

artículo científico publicado en 2017

Tau deposition patterns are associated with functional connectivity in primary tauopathies

artículo científico publicado en 2022

The FTD-like syndrome causing TREM2 T66M mutation impairs microglia function, brain perfusion, and glucose metabolism.

artículo científico publicado en 2017

The correlation between striatal and cortical binding ratio of 11C-PiB-PET in amyloid-uptake-positive patients

artículo científico publicado en 2018

Time Courses of Cortical Glucose Metabolism and Microglial Activity Across the Life Span of Wild-Type Mice: A PET Study

artículo científico publicado en 2017

Towards standardization of 18F-FET PET imaging: do we need a consistent method of background activity assessment?

artículo científico publicado en 2017

[18F]-THK5351 PET Correlates with Topology and Symptom Severity in Progressive Supranuclear Palsy.

artículo científico publicado en 2017

[18F]FDG PET accurately differentiates infected and non-infected non-unions after fracture fixation.

artículo científico publicado en 2016

[18F]MPPF and [18F]FDG μPET imaging in rats: impact of transport and restraint stress

scientific article published on 29 September 2020

[A Pair of Siblings with Frontotemporal Dementia and Amyotrophic Lateral Sclerosis and a Novel Thr462Lysfs Mutation in the TBK1 Gene].

artículo científico publicado en 2016

[Amyloid positron-emission-tomography with [18 F]-florbetaben in the diagnostic workup of dementia patients].

artículo científico publicado en 2016

[Posterior cortical atrophy-a heterogeneous syndrome : A case series]

artículo científico publicado en 2019

sTREM2 cerebrospinal fluid levels are a potential biomarker for microglia activity in early-stage Alzheimer's disease and associate with neuronal injury markers

artículo científico publicado en 2016

Lista de obras de

68Ga-TRAP-(RGD)3 Hybrid Imaging for the In Vivo Monitoring of αvß3-Integrin Expression as Biomarker of Anti-Angiogenic Therapy Effects in Experimental Breast Cancer

A novel real-space navigation paradigm reveals age- and gender-dependent changes of navigational strategies and hippocampal activation

Additive value of amyloid-PET in routine cases of clinical dementia work-up after FDG-PET.

Altered serotonin and dopamine transporter availabilities in brain of depressed patients upon treatment with escitalopram: A [123 I]β-CIT SPECT study.

Amyloid-PET predicts inhibition of de novo plaque formation upon chronic γ-secretase modulator treatment

Analysis of 18F-DMFP PET data using multikernel classification in order to assist the diagnosis of Parkinsonism

Applied multimodal diagnostics in a case of presenile dementia.

Assessment of 18F-PI-2620 as a Biomarker in Progressive Supranuclear Palsy

Associations of [18F]-APN-1607 Tau PET Binding in the Brain of Alzheimer's Disease Patients With Cognition and Glucose Metabolism

Asymmetry of fibrillar plaque burden in amyloid mouse models

Automated Spatial Brain Normalization and Hindbrain White Matter Reference Tissue Give Improved [(18)F]-Florbetaben PET Quantitation in Alzheimer's Model Mice

Cerebral Glucose Metabolism and Dopaminergic Function in Patients with Corticobasal Syndrome

Clinical Routine FDG-PET Imaging of Suspected Progressive Supranuclear Palsy and Corticobasal Degeneration: A Gatekeeper for Subsequent Tau-PET Imaging?

Clinical, ocular motor, and imaging profile of Niemann-Pick type C heterozygosity

Colocalization of Tau but Not β-Amyloid with Cortical Superficial Siderosis in a Case with Probable CAA

Comparison of 18F-GE-180 and dynamic 18F-FET PET in high grade glioma: a double-tracer pilot study

Comparison of 18F-T807 and 18F-THK5117 PET in a Mouse Model of Tau Pathology.

Coupling between physiological TSPO expression in brain and myocardium allows stabilization of late-phase cerebral [18F]GE180 PET quantification

Cross-sectional comparison of small animal [18F]-florbetaben amyloid-PET between transgenic AD mouse models

Data on specificity of [18F]GE180 uptake for TSPO expression in rodent brain and myocardium.

Depressive symptoms accelerate cognitive decline in amyloid-positive MCI patients

Detection of Cerebrospinal Fluid Dissemination of Recurrent Glioblastoma Using TSPO-PET With 18F-GE-180.

Direct comparison of activation maps during galvanic vestibular stimulation: A hybrid H2[15 O] PET-BOLD MRI activation study

Early and Longitudinal Microglial Activation but Not Amyloid Accumulation Predicts Cognitive Outcome in PS2APP Mice

Early static (18)F-FET-PET scans have a higher accuracy for glioma grading than the standard 20-40 min scans.

Early-phase [18F]PI-2620 tau-PET imaging as a surrogate marker of neuronal injury

Efficacy of chronic BACE1 inhibition in PS2APP mice depends on the regional Aβ deposition rate and plaque burden at treatment initiation

Evaluation of early-phase [18F]-florbetaben PET acquisition in clinical routine cases

Expression of Translocator Protein and [18F]-GE180 Ligand Uptake in Multiple Sclerosis Animal Models

FDG PET Data is Associated with Cognitive Performance in Patients from a Memory Clinic

FDG-PET in a Case of Very Late-onset Huntington's Disease

Four-repeat tauopathies

Glial Activation and Glucose Metabolism in a Transgenic Amyloid Mouse Model: A Triple-Tracer PET Study

Glial activation is moderated by sex in response to amyloidosis but not to tau pathology in mouse models of neurodegenerative diseases

Higher CSF sTREM2 and microglia activation are associated with slower rates of beta-amyloid accumulation

Hypometabolism in Brain of Cognitively Normal Patients with Depressive Symptoms is Accompanied by Atrophy-Related Partial Volume Effects

Identification of Distant Metastases From Recurrent Gliosarcoma Using Whole-Body 18F-FDG PET/CT

Identification of a rare presenilin 1 single amino acid deletion mutation (F175del) with unusual amyloid-β processing effects

Identification of brain regions predicting epileptogenesis by serial [18F]GE-180 positron emission tomography imaging of neuroinflammation in a rat model of temporal lobe epilepsy

IgLON5: A case with predominant cerebellar tau deposits and leptomeningeal inflammation

Imaging biomarkers of behavioral impairments: A pilot micro-positron emission tomographic study in a rat electrical post-status epilepticus model

Imaging correlates of behavioral impairments: An experimental PET study in the rat pilocarpine epilepsy model

Impact of MRI-based Segmentation Artifacts on Amyloid- and FDG-PET Quantitation

Impact of partial volume effect correction on cerebral β-amyloid imaging in APP-Swe mice using [(18)F]-florbetaben PET.

Improved Risk Stratification for Progression from Mild Cognitive Impairment to Alzheimer's Disease with a Multi-Analytical Evaluation of Amyloid-β Positron Emission Tomography

Improved longitudinal [(18)F]-AV45 amyloid PET by white matter reference and VOI-based partial volume effect correction

In Vivo Imaging of Glial Activation after Unilateral Labyrinthectomy in the Rat: A [18F]GE180-PET Study

In response to: Anatomy of 18F-GE180, a failed radioligand for the TSPO protein

In response to: The validity of 18F-GE180 as a TSPO imaging agent

Increase of TREM2 during Aging of an Alzheimer's Disease Mouse Model Is Paralleled by Microglial Activation and Amyloidosis

Laquinimod ameliorates secondary brain inflammation

Late-stage Anle138b treatment ameliorates tau pathology and metabolic decline in a mouse model of human Alzheimer's disease tau

Longitudinal PET Monitoring of Amyloidosis and Microglial Activation in a Second-Generation Amyloid-β Mouse Model

Longitudinal TSPO expression in tau transgenic P301S mice predicts increased tau accumulation and deteriorated spatial learning

Longitudinal assessment of cerebral β-amyloid deposition in mice overexpressing Swedish mutant β-amyloid precursor protein using 18F-florbetaben PET.

Loss of TMEM106B potentiates lysosomal and FTLD-like pathology in progranulin-deficient mice

Loss of TREM2 function increases amyloid seeding but reduces plaque-associated ApoE

Mapping 3-year changes in gray matter and metabolism in Aβ-positive nondemented subjects

Metabolic Correlates of Dopaminergic Loss in Dementia with Lewy Bodies

Metabolic patterns across core features in dementia with lewy bodies

Microglial response to increasing amyloid load saturates with aging: a longitudinal dual tracer in vivo μPET-study

Molecular imaging of cardiac CXCR4 expression in a mouse model of acute myocardial infarction using a novel 68Ga-mCXCL12 PET tracer

Monitoring of Tumor Growth with [(18)F]-FET PET in a Mouse Model of Glioblastoma: SUV Measurements and Volumetric Approaches

Monitoring of chronic γ-secretase modulator treatment by serial amyloid-PET.

Multivariate Analysis of 18F-DMFP PET Data to Assist the Diagnosis of Parkinsonism

Neuronal injury biomarkers for assessment of the individual cognitive reserve in clinically suspected Alzheimer's disease

Noradrenaline transporter availability on [11C]MRB PET predicts weight loss success in highly obese adults.

Opposite microglial activation stages upon loss of PGRN or TREM2 result in reduced cerebral glucose metabolism.

PET Imaging of Astrogliosis and Tau Facilitates Diagnosis of Parkinsonian Syndromes

Perfusion-Phase [18F]THK5351 Tau-PET Imaging as a Surrogate Marker for Neurodegeneration

Predicting Regional Pattern of Longitudinal β-Amyloid Accumulation by Baseline PET.

Prevalence of Amyloid Positron Emission Tomographic Positivity in Poststroke Mild Cognitive Impairment

Rate of β-amyloid accumulation varies with baseline amyloid burden: Implications for anti-amyloid drug trials

Real-space navigation testing differentiates between amyloid-positive and -negative aMCI

Reduced FDG-PET brain metabolism and executive function predict clinical progression in elderly healthy subjects

Reference region selection and the association between the rate of amyloid accumulation over time and the baseline amyloid burden

Relationship Between Body Mass Index, ApoE4 Status, and PET-Based Amyloid and Neurodegeneration Markers in Amyloid-Positive Subjects with Normal Cognition or Mild Cognitive Impairment

Serotonin Selective Reuptake Inhibitor Treatment Improves Cognition and Grey Matter Atrophy but not Amyloid Burden During Two-Year Follow-Up in Mild Cognitive Impairment and Alzheimer's Disease Patients with Depressive Symptoms

Small-Animal PET Imaging of Tau Pathology with 18F-THK5117 in 2 Transgenic Mouse Models